|
1
|
Clinical significance of circulating tumor cells in blood from patients with gastrointestinal cancers.
|
Ann Surg Oncol
|
2008
|
1.46
|
|
2
|
Tumor initiating potential of side population cells in human gastric cancer.
|
Int J Oncol
|
2009
|
1.42
|
|
3
|
Three-step esophagojejunal anastomosis with atraumatic anvil insertion technique after laparoscopic total gastrectomy.
|
J Gastrointest Surg
|
2011
|
1.16
|
|
4
|
Postoperative pancreatic fistula and the risk factors of laparoscopy-assisted distal gastrectomy for early gastric cancer.
|
Ann Surg Oncol
|
2011
|
1.09
|
|
5
|
Prognostic significance of complications after curative surgery for gastric cancer.
|
Ann Surg Oncol
|
2013
|
1.07
|
|
6
|
Long-term outcome and survival with laparoscopy-assisted pylorus-preserving gastrectomy for early gastric cancer.
|
Surg Endosc
|
2010
|
1.02
|
|
7
|
Phase II study of chemoradiotherapy with S-1 and low-dose cisplatin for inoperable advanced gastric cancer.
|
Int J Radiat Oncol Biol Phys
|
2007
|
1.01
|
|
8
|
Postoperative outcomes and complications after laparoscopy-assisted pylorus-preserving gastrectomy for early gastric cancer.
|
Ann Surg
|
2011
|
0.99
|
|
9
|
Postoperative pancreatic fistula formation according to ISGPF criteria after D2 gastrectomy in Western patients.
|
Gastric Cancer
|
2013
|
0.85
|
|
10
|
Laparoscopy-assisted subtotal gastrectomy with very small remnant stomach: a novel surgical procedure for selected early gastric cancer in the upper stomach.
|
Gastric Cancer
|
2011
|
0.80
|
|
11
|
Significance of the inflammation-based Glasgow prognostic score for short- and long-term outcomes after curative resection of gastric cancer.
|
J Gastrointest Surg
|
2012
|
0.78
|
|
12
|
Dynamic alteration of gene expression induced by anticancer-agent exposure in gastric cancer cell lines.
|
Oncol Rep
|
2009
|
0.77
|
|
13
|
The Added Value of Partial Stomach-partitioning to a Conventional Gastrojejunostomy in the Treatment of Gastric Outlet Obstruction.
|
J Gastrointest Surg
|
2015
|
0.76
|
|
14
|
Octreotide acetate enables the administration of chemoradiotherapy, including the oral anticancer drug S-1, in gastric cancer patients with malignant gastrointestinal obstruction.
|
Oncol Lett
|
2010
|
0.75
|
|
15
|
[Report of a case successfully treated with chemo-radiation against local recurrence after gastric cancer surgery].
|
Gan To Kagaku Ryoho
|
2009
|
0.75
|